The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 23, 2024

Filed:

Mar. 18, 2022
Applicants:

Mohammad Ali Khayamian, Tehran, IR;

Mohammad Abdolahad, Tehran, IR;

Hamed Abadijoo, Tehran, IR;

Mahsa Faramarzpour Darzini, Tehran, IR;

Mohammadreza Ghaderinia, Tehran, IR;

Hossein Simaee, Tehran, IR;

Seyed Mojtaba Yazdanparast, Tehran, IR;

Shahriar Shalileh, Tehran, IR;

Inventors:

Mohammad Ali Khayamian, Tehran, IR;

Mohammad Abdolahad, Tehran, IR;

Hamed Abadijoo, Tehran, IR;

Mahsa Faramarzpour Darzini, Tehran, IR;

Mohammadreza Ghaderinia, Tehran, IR;

Hossein Simaee, Tehran, IR;

Seyed Mojtaba Yazdanparast, Tehran, IR;

Shahriar Shalileh, Tehran, IR;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/05 (2021.01); A61B 5/053 (2021.01); A61N 1/04 (2006.01); A61N 1/32 (2006.01); A61N 1/40 (2006.01);
U.S. Cl.
CPC ...
A61B 5/053 (2013.01); A61N 1/0404 (2013.01); A61N 1/32 (2013.01); A61N 1/40 (2013.01);
Abstract

A method for preventing cytokine storm by suppressing clonal expansion of hyperactivated lymphocytes in a COVID-19 infected patient. The method includes placing at least four electrodes on skin of the COVID-19 infected patient by putting at least two electrodes at two locations over chest in front of ribcage of the COVID-19 infected patient and putting at least two other electrodes at two locations adjacent to lung tissue of the COVID-19 infected patient and suppressing mitosis of hyperactivated proliferative lymphocytes cells within the lung tissue of the COVID-19 infected patient by electrically stimulating the hyperactivated proliferative lymphocytes. Electrically stimulating the hyperactivated proliferative lymphocytes includes generating an alternating electric field (AEF) within the lung tissue by applying an AC voltage to the at least four electrodes and periodically changing a direction of the generated AEF in a plurality of directions within the lung tissue.


Find Patent Forward Citations

Loading…